NCT00074165 2023-07-06
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
OHSU Knight Cancer Institute
Phase 2 Terminated
Clinical Trials
1 trialsPhase 2 × Drug-Related Side Effects and Adverse Reactions × Granulocyte Colony-Stimulating Factor × Clear all